Sipuleucel-T (Provenge)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Sipuleucel-T (Provenge), covering 2010-09-02 to 2010-09-02. Get the full timeline:
Most recent: Clinical Trial Update: Immunotherapy With APC8015 (Sipuleucel-T, Provenge) for Asymptomatic, Metastatic, Hormone-Refractory Prostate Cancer [Phase 3]